Connor, Clark & Lunn Investment Management Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1596800 VANCOUVER, A1

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$20,255,683

-$14,675,485 QoQ

Shares Held

153,755

-37.6% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

19 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (16.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	649,629	$31,279,636
2	ZTS	Zoetis Inc.	187,329	$22,144,161
3	NBIX	Neurocrine Biosciences Inc This page	153,755	$20,255,683
4	TEVA	Teva Pharmaceutical Industries Ltd	471,891	$14,213,356
5	AMLX	Amylyx Pharmaceuticals, Inc.	868,325	$12,069,717
6	IRWD	Ironwood Pharmaceuticals Inc	1,835,424	$6,442,338
7	EBS	Emergent BioSolutions Inc.	648,377	$5,381,529
8	RDY	Dr Reddys Laboratories Ltd	382,976	$5,304,217

All Filings in NBIX

Export CSV

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,255,683	153,755	-37.6%	Shares	Sole	2026-05-11
2025-12-31	$34,931,168	246,289	-12.4%	Shares	Sole	2026-02-10
2025-09-30	$39,462,642	281,113	+13.1%	Shares	Sole	2025-11-13
2025-06-30	$31,250,681	248,633	+345.1%	Shares	Sole	2025-08-07
2025-03-31	$6,178,669	55,865	-12.1%	Shares	Sole	2025-05-12
2024-12-31	$8,678,943	63,582	+270.0%	Shares	Sole	2025-02-10
2024-09-30	$1,980,170	17,186	+670.7%	Shares	Sole	2024-11-08
2024-06-30	$307,004	2,230	-92.0%	Shares	Sole	2024-08-09
2023-12-31	$3,678,870	27,921	-60.2%	Shares	Sole	2024-02-09
2023-09-30	$7,882,762	70,069	-56.8%	Shares	Sole	2023-11-13
2023-06-30	$15,301,966	162,269	-32.7%	Shares	Sole	2023-08-10
2023-03-31	$24,415,883	241,216	+36.6%	Shares	Sole	2023-05-10
2022-12-31	$21,093,581	176,604	-10.5%	Shares	Sole	2023-02-10
2022-09-30	$20,956,082	197,308	-8.1%	Shares	Sole	2022-11-10
2022-06-30	$20,928,663	214,697	+2.4%	Shares	Sole	2022-08-05
2022-03-31	$19,649,906	209,599	+302.4%	Shares	Sole	2022-05-12
2021-12-31	$4,436,249	52,087	+1035.8%	Shares	Sole	2022-02-10
2021-03-31	$445,988	4,586	-56.3%	Shares	Sole	2021-05-13
2020-09-30	$1,009,583	10,499	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.